Is lenalidomide a new standard treatment for myelodysplastic syndrome?
Kuendgen
Andrea
A
Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany. andrea@ta2000.de